How is leptospirosis diagnosed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Diagnose Leptospirosis

Diagnose leptospirosis through a combination of serologic testing (IgM ELISA and microscopic agglutination test) after 6-10 days of symptoms, or blood/CSF cultures within the first 5 days before antibiotics, guided by clinical presentation of fever, myalgia (especially calves), and conjunctival suffusion in patients with water or animal urine exposure. 1

Clinical Suspicion and Timing

Suspect leptospirosis in patients presenting with:

  • Fever, headache, chills, and myalgia (particularly calf muscles) 1
  • Conjunctival suffusion (highly suggestive finding) 1
  • Biphasic illness pattern: initial bacteremic phase with flu-like symptoms (4-7 days), followed 1-3 days later by immune phase with fever, hepatorenal syndrome, and hemorrhage 1
  • Exposure history: contact with urine-contaminated water, recreational water sports, occupational animal exposure, or flooding 1

Diagnostic Algorithm by Timing

Early Disease (First 5 Days of Symptoms)

Blood and CSF cultures are the primary diagnostic method during the bacteremic phase 1:

  • Collect aerobic blood cultures before antibiotics 1
  • Keep blood cultures at room temperature prior to dispatch to reference laboratory 1
  • CSF cultures can also be obtained if meningeal signs present 1
  • Urine is NOT a suitable sample for isolation of leptospira 1

After 6-10 Days of Symptoms

Serologic testing becomes the primary diagnostic method 1:

Initial serology:

  • IgM ELISA is the rapid screening test 1
  • IgM titer ≥1:320 is considered suggestive of leptospirosis 1
  • Titers of 1:80 to 1:160 are consistent with early infection but may represent cross-reactions 1

Confirmatory testing:

  • Convalescent serology >10 days after symptom onset should include both IgM ELISA and microscopic agglutination test (MAT) 1
  • MAT is the gold standard serologic test 2, 3
  • Earliest positive serology appears 6-10 days after onset of symptoms 1

Supportive Laboratory Findings

Initial investigations are non-specific but may show 1:

  • Urinalysis: proteinuria and hematuria 1
  • Hematology: polymorphonuclear leukocytosis, thrombocytopenia, anemia if hemorrhage occurred 1
  • Coagulation: often normal despite bleeding (due to capillary fragility) 1
  • Biochemistry: renal failure, high bilirubin with mild transaminase elevation 1

Case Classification

Probable case 1:

  • Clinically compatible presentation (fever, headache, chills, myalgia, conjunctival suffusion)
  • Supportive serology: Leptospira agglutination titer ≥1:200 in one or more serum specimens

Confirmed case 1:

  • Isolation of Leptospira from clinical specimen, OR
  • Fourfold or greater increase in Leptospira agglutination titer between acute and convalescent sera obtained ≥2 weeks apart, OR
  • Demonstration of Leptospira by immunofluorescence in clinical specimen

Critical Pitfalls to Avoid

  • Do not wait for laboratory confirmation to initiate treatment given the non-specific nature of initial investigations and potential for rapid deterioration 1
  • Do not send urine for culture as it is not suitable for leptospira isolation 1
  • Do not store blood cultures in refrigerator—maintain at room temperature before sending to reference lab 1
  • Do not rely on single acute-phase serology—convalescent titers are needed for confirmation 1
  • Recognize that severe disease (Weil's disease) may not respond to antibiotics as it is immunologically mediated 1

Modern Diagnostic Considerations

While not widely available, PCR amplification of bacterial DNA from blood during the first week can provide rapid diagnosis 4, and loop-mediated isothermal amplification (LAMP) and CRISPR-based approaches represent emerging diagnostic technologies 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diagnosis of leptospirosis and comparison of ELISA and MAT techniques.

Indian journal of pathology & microbiology, 2006

Research

Diagnosis and epidemiology of leptospirosis.

Medecine et maladies infectieuses, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.